Prophylactic Effects of Psilocybin on Chronic Cluster Headache (EPOCH)
Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study
Sponsor: Gitte Moos Knudsen
Terminated
Not possible to achieve the anticipated no. of patients due to Covid-19 pandemic
Other terminated trials from Gitte Moos Knudsen
More terminations from Gitte Moos Knudsen
Other Cluster Headache trials with similar outcome
This PHASE1/PHASE2 trial investigates Cluster Headache and is currently terminated or withdrawn. Gitte Moos Knudsen leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Sep 2022 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
Status: Unknown Status → Terminated
-
Mar 2022 — Sep 2022 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 1 earlier version
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gitte Moos Knudsen
For direct contact, visit the study record on ClinicalTrials.gov .